|

Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer

RECRUITINGSponsored by Seoul National University Hospital
Actively Recruiting
SponsorSeoul National University Hospital
Started2022-06-22
Est. completion2027-05-31
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted

Summary

This study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Those with newly diagnosed ovarian cancer, fallopian tube cancer and primary peritoneal carcinomatosis who plan to undergo cytoreductive surgery and secondary cytoreductive surgery after neoadjuvant chemotherapy.
* Patients with PCDS or rectal and sigmoid coloni tumor invasion suspected on the preoperative image and need resection of the tumor and clinical FIGO stage IIIB or higher
* ECOG performance status : 0-2
* Age over 18

Exclusion Criteria:

* Patient who underwent low anterior resection in the past
* Past history of gastrointestinal malignant tumor except to ovarian cancer
* Patient who have colostomy
* Patient who underwent radiation therapy to abdominal or pelvic cavity
* ECOG performance status over 3
* Patient taking opioid analgesics
* Patient who have intellectual disability or dementia

Conditions4

CancerLow Anterior Resection SyndromeOvarian CancerQuality of Life

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.